These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 25081899)

  • 41. Non-Hodgkin lymphoma in Romania: a single-centre experience.
    Fetica B; Achimas-Cadariu P; Pop B; Dima D; Petrov L; Perry AM; Nathwani BN; Müller-Hermelink HK; Diebold J; MacLennan KA; Fulop A; Blaga ML; Coza D; Nicula FA; Irimie A; Weisenburger DD
    Hematol Oncol; 2017 Jun; 35(2):198-205. PubMed ID: 26482423
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).
    Baras N; Dahm S; Haberland J; Janz M; Emrich K; Kraywinkel K; Salama A
    Br J Haematol; 2017 Apr; 177(2):226-242. PubMed ID: 28106907
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Family history of hematopoietic malignancy and risk of lymphoma.
    Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
    J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incidence of autoimmune diseases in a nationwide HIV/AIDS patient cohort in Taiwan, 2000-2012.
    Yen YF; Chuang PH; Jen IA; Chen M; Lan YC; Liu YL; Lee Y; Chen YH; Chen YA
    Ann Rheum Dis; 2017 Apr; 76(4):661-665. PubMed ID: 27590658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinic-pathologic characteristics of autoimmune diseases combined with non-Hodgkin's lymphoma].
    Yu YP; Liu HN; Zhai YP; Shi P; Song P; Li F; Zhou XG; Tang YM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):124-9. PubMed ID: 21362236
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Periodontal disease and risk of non-Hodgkin lymphoma in the Health Professionals Follow-Up Study.
    Bertrand KA; Shingala J; Evens A; Birmann BM; Giovannucci E; Michaud DS
    Int J Cancer; 2017 Mar; 140(5):1020-1026. PubMed ID: 27861844
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cause-specific mortality among Medicare beneficiaries with newly diagnosed non-Hodgkin lymphoma subtypes.
    Hester LL; Park SI; Wood WA; Stürmer T; Brookhart MA; Lund JL
    Cancer; 2019 Apr; 125(7):1101-1112. PubMed ID: 30548238
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A closer look at non-Hodgkin's lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case-control study.
    Löfström B; Backlin C; Sundström C; Ekbom A; Lundberg IE
    Ann Rheum Dis; 2007 Dec; 66(12):1627-32. PubMed ID: 17517757
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adolescent weight and height are predictors of specific non-Hodgkin lymphoma subtypes among a cohort of 2,352,988 individuals aged 16 to 19 years.
    Leiba M; Leiba A; Keinan-Boker L; Avigdor A; Derazne E; Levine H; Kark JD
    Cancer; 2016 Apr; 122(7):1068-77. PubMed ID: 26900677
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The epidemiology of non-Hodgkin lymphoma.
    Grulich AE; Vajdic CM
    Pathology; 2005 Dec; 37(6):409-19. PubMed ID: 16373224
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk of subsequent solid tumors after non-Hodgkin's lymphoma: effect of diagnostic age and time since diagnosis.
    Hemminki K; Lenner P; Sundquist J; Bermejo JL
    J Clin Oncol; 2008 Apr; 26(11):1850-7. PubMed ID: 18347006
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Familial risk of non-Hodgkin lymphoma by sex, relationship, age at diagnosis and histology: a joint study from five Nordic countries.
    Fallah M; Kharazmi E; Pukkala E; Tretli S; Olsen JH; Tryggvadottir L; Sundquist K; Hemminki K
    Leukemia; 2016 Feb; 30(2):373-8. PubMed ID: 26442613
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci.
    Wang SS; Vajdic CM; Linet MS; Slager SL; Voutsinas J; Nieters A; de Sanjose S; Cozen W; Alarcón GS; Martinez-Maza O; Brown EE; Bracci PM; Lightfoot T; Turner J; Hjalgrim H; Spinelli JJ; Zheng T; Morton LM; Birmann BM; Flowers CR; Paltiel O; Becker N; Holly EA; Kane E; Weisenburger D; Maynadie M; Cocco P; Foretova L; Staines A; Davis S; Severson R; Cerhan JR; Breen EC; Lan Q; Brooks-Wilson A; De Roos AJ; Smith MT; Roman E; Boffetta P; Kricker A; Zhang Y; Skibola C; Chanock SJ; Rothman N; Benavente Y; Hartge P; Smedby KE
    Am J Epidemiol; 2015 Mar; 181(6):406-21. PubMed ID: 25713336
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up.
    Tadmor T; Liphshitz I; Silverman B; Polliack A
    Hematol Oncol; 2017 Dec; 35(4):599-607. PubMed ID: 27238496
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Malignant lymphomas and autoimmunity-a single center experience from Hungary.
    Váróczy L; Páyer E; Kádár Z; Gergely L; Miltényi Z; Magyari F; Szodoray P; Illés A
    Clin Rheumatol; 2012 Feb; 31(2):219-24. PubMed ID: 21735057
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case-control study.
    Engels EA; Cerhan JR; Linet MS; Cozen W; Colt JS; Davis S; Gridley G; Severson RK; Hartge P
    Am J Epidemiol; 2005 Dec; 162(12):1153-61. PubMed ID: 16251389
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence and Pattern of Autoimmune Conditions in Patients with Marginal Zone Lymphoma: A Single Institution Experience.
    Dasanu CA; Bockorny B; Grabska J; Codreanu I
    Conn Med; 2015 Apr; 79(4):197-200. PubMed ID: 26259295
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Presence of autoimmune disease affects not only risk but also survival in patients with B-cell non-Hodgkin lymphoma.
    Kleinstern G; Averbuch M; Abu Seir R; Perlman R; Ben Yehuda D; Paltiel O
    Hematol Oncol; 2018 Apr; 36(2):457-462. PubMed ID: 29469175
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Age-time risk patterns of solid cancers in 60 901 non-Hodgkin lymphoma survivors from Finland, Norway and Sweden.
    Lorenzo Bermejo J; Pukkala E; Johannesen TB; Sundquist J; Hemminki K
    Br J Haematol; 2014 Mar; 164(5):675-83. PubMed ID: 24528128
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hyperemesis, gestational hypertensive disorders, pregnancy losses and risk of autoimmune diseases in a Danish population-based cohort.
    Jørgensen KT; Nielsen NM; Pedersen BV; Jacobsen S; Frisch M
    J Autoimmun; 2012 May; 38(2-3):J120-8. PubMed ID: 22226784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.